Status:

NOT_YET_RECRUITING

Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism

Lead Sponsor:

Insel Gruppe AG, University Hospital Bern

Conditions:

Venous Thromboembolism (VTE)

Exercise Therapy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Up to half of patients with pulmonary embolism (PE) suffer from impaired quality of life, reduced physical capacity, and symptoms like shortness of breath even three months after diagnosis, despite st...

Eligibility Criteria

Inclusion

  • Age ≥18 years
  • Hospitalization for objectively confirmed acute symptomatic PE, defined as intraluminal filling defect of a segmental or more proximal pulmonary artery on computed tomography pulmonary angiography (CTPA) or a high-probability ventilation-perfusion scintigraphy, and admission within the past 7 days
  • Increased risk for post-PE syndrome, defined as simplified Pulmonary Embolism Severity Index (sPESI) ≥1 point at the time of admission
  • Written informed consent

Exclusion

  • Contraindication to EBR (known unstable cardiac conditions like angina pectoris, severe valvular heart disease, or severe resting pulmonary hypertension)
  • Medical condition that clearly precludes participation in EBR (e.g., inability to walk, unstable joints, severe neurological impairment)
  • Recently completed (i.e., \<6 months), ongoing, or planned in- or outpatient EBR, or planned supervised outpatient physiotherapy for any indication
  • Planned hospitalization during follow-up (e.g., elective surgery or inpatient chemotherapy)
  • Contraindication to anticoagulation
  • Life expectancy \<1 year based on the treating physician's clinical judgement
  • Known pregnancy
  • Inability to speak German or French
  • Participation in another study that prohibits concurrent participation in RehabPE
  • Unable to provide informed consent (e.g., due to dementia)
  • Unwilling to provide informed consent
  • Prior enrollment in this study

Key Trial Info

Start Date :

October 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2028

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT07143539

Start Date

October 1 2025

End Date

March 1 2028

Last Update

August 27 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Inselspital, Bern University Hospital

Bern, Switzerland, 3010